Adina Mangubat has held leadership positions in two high technology start-up companies focused in the distributed computing space. In both companies her role included team development, executive team management, brand development, marketing, channel development and sales for complex technologies with consumer facing products. Additionally, her roles in both companies focused on consumer education around scale able product portfolios. She holds a B.S. in Psychology with a focus on Biopsychology, Psychopharmacology and Entrepreneurship.
Becky Drees, Ph.D – Chief Scientific Officer
Dr. Drees is an accomplished molecular biologist. Becky’s professional background includes research on genome wide protein-protein interaction networks at the University of Washington, genetic interaction maps at the Institute for Systems Biology, and expression profiling of lymphocytes for HIV research at the Fred Hutchinson Cancer Research Institute. Her areas of scientific expertise include high-throughput screening, genome annotation, gene expression analysis, and next generation sequencing technologies. She holds a B.S. in Biochemistry from Texas A&M University and a Ph.D. in Molecular Biology from the University of California, Berkeley.
Jeremy Bruestle – Chief Technical Officer
Well known for the publication of Airsnort, a tool that revealed security flaws in early Wifi networks and his work on a laser based mosquito killer, Jeremy has an extensive background in distributed computing. At his previous venture, CoCo Communications, he managed the growth of the company from a seed company to a company with a 50-person development team. Jeremy has a patent portfolio with five issued patents and he specializes in bridging the gap between academic research and applied technology. Recent projects include a parallel processing engine for cellular image analysis and an advanced retinal imaging system, developed in conjunction with researchers at Indiana University.
Eric Schadt, Ph.D.
Dr. Schadt is Director of the Institute for Genomics and Multiscale Biology, Chair of the Department of Genetics and Genomics Sciences at the Mount Sinai School of Medicine. Dr. Schadt is an expert on the generation and integration of very large-scale sequence variation, molecular profiling and clinical data in disease populations for constructing molecular networks that define disease states and link molecular biology to physiology. He has contributed to a number of discoveries relating to the genetic basis of common human diseases such as diabetes and obesity, which have been widely published in leading scientific journals. Dr. Schadt is also a co-founder of Sage Bionetworks. Prior to joining Pacific Biosciences in 2009, he was Executive Scientific Director of Genetics at Rosetta Inpharmatics, a subsidiary of Merck & Co., Inc. in Seattle. He received his B.A. in applied mathematics and computer science from California Polytechnic State University, his M.A. in pure mathematics and his Ph.D. in bio-mathematics from University of California, Los Angeles.
Lawrence Fagan, M.D., Ph.D.
Dr. Fagan has over 30 years of experience in the development and management of computer applications in support of medical care (medical informatics). He is the Co-Director of the Stanford Biomedical Informatics Training Program. In this capacity, he helped develop and manage one of the earliest cancer data management systems, as well as novel user interfaces for describing the structure of cancer clinical trials. He has extensive experience with pen-based graphical user interfaces for structured data entry of clinical notes and other user interface modalities including spoken input and 3D displays. Most recently, he worked on a project for the National Cancer Institute to translate cancer medical records into structured information using natural language processing techniques. Dr. Fagan's undergraduate training was in Interdisciplinary Science at M.I.T, his Ph.D. in Computer Science at Stanford University, and his MD at the University of Miami.
Deborah Kessler was Executive Director of Merck Research Laboratories, headed the Gene Expression Laboratory and held the position of Chief Operating Officer for Rosetta Inpharmatics, LLC. Prior to her role with Merck , Ms. Kessler applied her experience in the medical product industry holding positions in R&D and manufacturing for Spacelabs Medical, Inc and Siemens Ultrasound. Ms. Kessler spent a large part of her career as an Engineer at the NASA Johnson Space Center where her accomplishments include working as a Flight Dynamics Officer in the Mission Control Center. Deborah has a B.S. in Mechanical Engineering from the University of Maryland and a M.S. in Electrical Engineering from the University of Houston.
Christophe is a distributed computing expert. He founded WibiData in 2010 after having founded Cloudera, the leading provider of Apache Hadoop-based software and services. Previously he was a senior software engineer at Google where he founded the Academic Cloud Computing Initiative which provides Google-hosted computational resources, in partnership with the National Science Foundation, to facilitate research and education involving large scale, data-intensive, computing systems. Previously at Google, Christophe developed and taught a course at the University of Washington on the MapReduce data processing model and related topics in distributed computing. He holds a B.S. in Computer Science from the University of Washington.
Tim Hunkapiller, Ph.D.
Dr. Hunkapiller has over 20 years of experience in bioinformatics, algorithm and database development as well as experimental process optimization. He is well known for creating the model for the automated, fluorescent DNA sequencer. Utilizing this model, products such as the ABI 3700 and the MD Megabase sequencers catalyzed and enabled the completion of the first drafts of the Human Genome. Dr. Hunkapiller's research focus has included molecular immunology, evolution, computational genetics, comparative genomics and he is an expert on the genetics, genomic organization and functional diversity of the immune system. He continues to work with Applied Biosystems to improve the throughput and quality of data from these instruments and their associated chemistry. Dr. Hunkapiller received his Ph.D. from the California Institute of Technology in Molecular Biology, and most recently has held a Research Assistant Professor appointment in the Department of Molecular Biotechnology at the University of Washington.
Gillian Muessig is the founding president of SEOmoz, providers of the world's most popular search marketing applications. SEOmoz.org serves a community of more than 300,000 search marketers around the world and the SEOmoz blog is read by over 50,000 people each month. Known as SEOmom throughout the industry, Gillian is a thought leader with her finger on the pulse of the future of the industry. She has provided keynotes and sessions for conferences in North and South America, Asia, Australia, Europe, Scandinavia and the UK.
Alan Leong, Ph.D.
Alan Leong is the co-founder and Director of Research for Biotech Stock Research. He was the Founder and Director of the Center for Student Entrepreneurship at the University of Washington – Bothell. In his capacity at the University of Washington -Bothell and during his tenure Dr. Leong was honored with multiple teaching awards. Dr. Leong is an active professor at the University of Washington and serves as the Director of the Student Venture Associates Program for the "W" Fund at the Center for Commercialization. He holds a Ph.D. in Social Sciences from The University of Southern California, an MSE in Engineering from the University of Washington and a B.S. in Management and Systems Science from Simon Fraser University. Dr. Leong is a member of Sigma Xi.
Named CFO of the year by Puget Sound Business Journal in 2010 for his CFO role at Seattle advertising firm Cole & Weber, Richard Jacroux has a 20 year background in financial management and accounting. Jacroux served for five years as the CFO for Cole and Weber, Inc., and worked for a number of years in leading accounting firms including Ernst & Young. He received his MBA from the Kellogg Graduate School of Management and holds a BA in accounting from the University of Washington’s Foster School of Business.